中国临床药学杂志

目的 分析2018-2020年我院麻醉药品在手术室的应用情况，探讨手术用麻醉药品的合理使用和规范化管理。方法 利用我院内网及HIS系统，收集2018年1月到2020年12月手术患者麻醉药品用量、金额等数据，分析该3年中手术用麻醉药品的使用情况。结果 我院共有手术用麻醉药品5种。受新冠疫情因素影响，2020年手术用麻醉药品用量较前大幅减少。2018-2020年我院手术用麻醉药品的DDDs和DDC排名没有发生变化，DDDs排名居于第一的为注射用盐酸瑞芬太尼，DDC排名位居第一的为盐酸羟考酮注射液，B/A值> 1的为枸橼酸芬太尼注射液。结论 我院手术用麻醉药品的使用总体比较合理，但仍需加强监测和规范化管理。

AIM To analyze the application of narcotic drugs in operation room of our hospital from 2018 to 2020,and explore the rational use and standardized management of narcotic drugs for operation. METHODS Using the intranet and HIS system of our hospital, the consumption and amount of narcotic drugs of surgical patients from January 2018 to December 2020 were collected to analyze the use of narcotic drugs for surgery in 3 years. RESULTS There were 5 kinds of narcotic drugs for surgery in our hospital. Due to the influence of COVID-19, the use of narcotic drugs for surgery decreased significantly in 2020 than before. There was no changes in DDDs(defined daily doses) and DDC(defined daily cost) ranking of narcotic drugs for surgery in our hospital from 2018 to 2020. Remifentanil hydrochloride for injection ranked the first in DDDs, oxycodone hydrochloride injection ranked the first in DDC, and fentanyl citrate injection was more economical(B/A > 1). CONCLUSION The use of narcotic drugs for surgery in our hospital is generally reasonable, but monitoring and standardized management still need to be strengthened.